Schwappach, D. L. B.
Taxis, Katja
Pfeiffer, Yvonne
Funding for this research was provided by:
Krebsforschung Schweiz (KFS-3496-08-2014)
Hanela-Stiftung
Article History
Received: 17 February 2016
Accepted: 12 February 2018
First Online: 17 February 2018
Authors’ information
: DS, PhD, MPH. Scientific director Swiss Patient Safety Foundation.KT, PhD, MSc. Professor of Pharmacotherapy and Clinical PharmacyYP, PhD. Research associate Swiss Patient Safety Foundation
: Return of the survey was regarded informed consent. The study was deemed exempt by the Cantonal ethics committee (KEK ZH Nr. 34–2015).
: Not applicable.
: The authors declare that they have no competing interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.